University Hospital Vall d'Hebron, Barcelona (Spain)
1
presentation
0
follower
3
more
presentations
in this session
Wild type transthyretin cardiac amyloidosis (wtATTR) and heart failure with reduced ejection fraction (HFrEF): can angiotensin receptor/neprilysin inhibitors be a therapeutic option?